High blood pressure, or hypertension, happens when the force of blood in the arteries stays high over time. It can lead to ...

The Dermatology Devices market is expected to grow at a compound annual growth rate (CAGR) of 6.5% over the forecast period, ...

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

US FDA accepts Bristol Myers Squibb’s sNDA for Sotyktu to treat adults with active psoriatic arthritis: Princeton, New Jersey Tuesday, July 22, 2025, 12:00 Hrs [IST] Bristol Mye ...

Icotrokinra was jointly discovered and is being developed pursuant to the license and collaboration agreement between ...

When blood flow to the brain is disrupted, the effects can be sudden and frightening — but early recognition and timely care ...

A recent article published by Impact Wealth Magazine highlights a significant paradigm shift within the financial services industry: wellness is no longer a mere perk but has become the “ultimate ...

The submission is supported by four Phase III clinical trials, which showed that icotrokinra demonstrated significant skin ...

The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for deucravacitinib for the treatment of adults with active psoriatic arthritis (PsA).

TORONTO, ONTARIO / ACCESS Newswire / July 21, 2025 / Royal LePage Terrequity Realty has been honoured with the 2025 Consumer Choice Award in the Residential Real Estate category for Toronto Central, ...

LP usually appears as small purple or red irritated bumps on the scalp and in some cases, it can cause hair loss. On other ...

China: A recent Mendelian randomization (MR) study has revealed that psoriasis may be inversely associated with uterine ...